...
首页> 外文期刊>Thyroid: official journal of the American Thyroid Association >In thyroidectomized patients with thyroid cancer, a serum thyrotropin of 30 ??u/ml after thyroxine withdrawal is not always adequate for detecting an elevated stimulated serum thyroglobulin
【24h】

In thyroidectomized patients with thyroid cancer, a serum thyrotropin of 30 ??u/ml after thyroxine withdrawal is not always adequate for detecting an elevated stimulated serum thyroglobulin

机译:在甲状腺癌切除的甲状腺癌患者中,甲状腺素停药后血清促甲状腺激素浓度为30μu/ ml并不总是足以检测出刺激性血清甲状腺球蛋白升高

获取原文
获取原文并翻译 | 示例
           

摘要

Background: The thyrotropin (TSH) level or duration of thyroid hormone withdrawal (THW) required to detect stimulated thyroglobulin (Tg) in differentiated thyroid cancer (DTC) monitoring is unknown. The objective of this study was to evaluate the TSH cutoff of >30 ??U/mL as a means to detect stimulated Tg ??2 ng/mL after THW (THW-Tg??2), and sensitivity of the Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-F) questionnaire for detecting hypothyroid symptoms. Methods: This was a prospective longitudinal cohort study done at a tertiary academic medical center. Forty-seven patients with DTC undergoing their first Tg stimulation or after previously abnormal Tg stimulation had weekly measurements of TSH and Tg during the 4 weeks THW, and repeated questionnaire assessments. Results: TSH did not reach a plateau in any patient, and in those whose Tg did not remain undetectable, Tg continued to rise. Seventy-five percent of patients had an undetectable Tg <0.2 ng/mL at baseline (95% were <0.5 mg/mL) with 16% remaining undetectable throughout THW. The majority of patients (72.7% and 97.8%) achieved TSH >30 ??U/mL by 3 and 4 weeks THW, respectively. Of the 15 patients with maximum stimulated THW-Tg??2, 38% were detected before the minimal TSH >30 ??U/mL cutoff. At 2 weeks THW, 3 had a TSH>30 ??U/mL, and none of them had Tg ??2 ng/mL. At 3 weeks THW, 11 had a TSH >30 ??U/mL, and 64% of them had Tg ??2 ng/mL. Only 60% were detected at 3-week THW regardless of their TSH level. Eighty-six percent were detected by TSH 60-<80 ??U/mL. Conversely, all patients whose serum Tg was <0.2 ng/mL when their serum TSH was >20 ??U/mL did not achieve a THW-Tg??2. Conclusion: The minimal TSH cutoff of >30 ??U/mL was inadequate to detect many patients with final stimulated THW-Tg??2 during complete THW. TSH >80-100 ??U/mL was a better cutoff, achieved in only 53% after 4-week THW. Conversely, we propose a preliminary THW-stopping rule for ending THW early in selected patients. In patients with a Tg <0.2 ng/mL when TSH >20 ??U/mL, all had a final stimulated Tg ??2 ng/mL, potentially saving qualifying patients 40% of THW duration compared to 4-week THW. FACIT-F correlated with TSH, but was not sensitive to detect mild hypothyroidism. ? 2013, Mary Ann Liebert, Inc.
机译:背景:在分化型甲状腺癌(DTC)监测中检测刺激性甲状腺球蛋白(Tg)所需的促甲状腺激素(TSH)水平或甲状腺激素戒断时间(THW)尚不清楚。这项研究的目的是评估TSH截止值> 30ΔU/ mL,作为检测THW(THW-TgΔ2)后刺激的TgΔ2 ng / mL(THW-TgΔ2)的方法,以及对慢性疾病治疗疲劳问卷(FACIT-F),用于检测甲状腺功能减退症状。方法:这是在三级学术医学中心进行的前瞻性纵向队列研究。接受首次Tg刺激或先前异常Tg刺激后的47例DTC患者在THW的4周内每周测量TSH和Tg,并重复进行问卷调查。结果:TSH在任何患者中均未达到平稳状态,而在那些Tg仍未检出的患者中,Tg继续升高。百分之七十五的患者基线时Tg <0.2 ng / mL(95%<0.5 mg / mL),在整个THW中仍未检测到。大多数患者(72.7%和97.8%)在THW的3周和4周时均达到了TSH> 30 U / mL。在15例最大THW-Tgβ2刺激患者中,有38%在最小TSH> 30ΔU/ mL临界值之前被检测到。在THW 2周时,有3个的TSH> 30 U / mL,没有一个Tg≥2 ng / mL。在THW 3周时,有11个的TSH> 30 U / mL,其中64%的Tg≥2 ng / mL。无论其TSH水平如何,在THW 3周时仅检测到60%。 TSH 60- <80 U / mL检测出86%。相反,当血清TSH> 20ΔU/ mL时,所有血清Tg <0.2 ng / mL的患者均未达到THW-TgΔ2。结论:最小TSH临界值> 30 UU / mL不足以检测出在完全THW期间许多最终受刺激的THW-Tg ?? 2患者。 TSH> 80-100 µU / mL是更好的临界值,THW 4周后仅达到53%。相反,我们提出了初步的THW停止规则,以在选定的患者中尽早结束THW。当TSH> 20ΔU/ mL时,Tg <0.2 ng / mL的患者,所有患者的最终TgΔ2 ng / mL均被刺激,与4周THW相比,潜在的合格患者可节省THW时间的40%。 FACIT-F与TSH相关,但对检测轻度甲状腺功能减退不敏感。 ? 2013年,玛丽·安·利伯特(Mary Ann Liebert,Inc.)

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号